But bearing in mind its role in preadipocyte proliferation and differentiation, insulin signalling, and correlation with state of fibrosis in human liver, miR‐199a‐5p still poses as a strong candidate for the potential NAFLD development marker. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.